Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Research

| More

Maintain BUY on Cholamandalam Investment & Finance - A mostly good show - HDFC Securities

Posted On: 2020-08-04 09:38:47


Mr. Darpin Shah, Institutional Research Analyst, HDFC Securities.

CIFC's 1QFY21 performance was ahead of our estimates on account of lower provisions. The management believes that COVID-19 related provisions made in 4QFY20 are sufficient. While we have reduced our provision estimates, they remain conservative. CIFC's 1QFY21 disbursal performance is creditable, given the challenging environment. The company remains our top NBFC pick, its ability to access funds, strong capital position, and diversified portfolio will enable the company to capture resurgent growth. Maintain BUY with a target price of Rs 249 (2.2xFY22E ABV).

Funding and liquidity trends: CIFC reported a 6.2/6.4% YoY/QoQ growth in borrowings to Rs 585bn. After declining significantly over the past two quarters, CPs outstanding saw a sharp QoQ growth (~2.5x) but were 25.7% lower YoY. Bank borrowings grew 43.2% - the fastest-growing borrowing sub-segment (YoY). Even though cash and cash equivalents rose 37.7/15.7% to Rs 80bn (available liquidity was ~Rs 110bn, including undrawn lines), the ALM position seems to have worsened QoQ, with shrinkage in cumulative quarterly surpluses across buckets. This may be on account of changes in anticipated inflows from advances. However, we do not find this worrisome as the company has been consistently well-placed on this front.

Moratorium and asset quality trends: The 7.7% QoQ fall in GS-III to ~Rs 20bn (3.3%) appears promising. However, this would have been assisted by the standstill classification. Further, ~74% of the portfolio remains under moratorium and ~50% of borrowers under moratorium paid at least one instalment. As sporadic local lockdowns occur across the country, flows from the moratorium portfolio will be watched.

Provisions: After the spike in 4QFY20, surprisingly, non-tax provisions registered a 48.7/89.9% fall to Rs 562mn. The management felt that it had adequately provided for COVID-19 related stress (in 4QFY20) and that coverage on GS-III (41.6%, -510/+12bps), more than adequately captured expected LGDs. However, given, that ~50% of the moratorium borrowers have not paid a single instalment, and sporadic lockdowns across the country, we have conservatively factored in non-tax provisions of 1.4% of average assets over FY21-22E.

Margin trends: NIMs dipped 40/50bps to 6.1%, as the fall in yields (-80/-90bps) outpaced the fall in CoF (-40/30bps). CIFC maintained a higher proportion of liquid assets in the quarter, and these assets saw a significant decline in yields. This, along with certain write-offs in the VF portfolio was responsible for the dip in overall yields. We expect CIFC to earn NIMs of 6.4% over FY21-22E.

Shares of Cholamandalam Investment and Finance Company Ltd was last trading in BSE at Rs.200.65 as compared to the previous close of Rs. 201.25. The total number of shares traded during the day was 373278 in over 5473 trades.

The stock hit an intraday high of Rs. 205.5 and intraday low of 198.5. The net turnover during the day was Rs. 75488212.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Zydus Wellness - Leadership in niche categories; initiate at BUY - ICICI Securities

Power - Setting the stage - ICICI Securities

Company Update - Elgi Equipments - ICICI Securities

Nano Nivesh - The Anup Engineering - ICICI Securities

RBI OMO announcement of Rs. 10000 crore - Angel Broking

TCS deal win - Sep 24, 2020 - Angel Broking

View on Pre-Monetary Policy by Upasna Bhardwaj, Senior Economist at Kotak Mahindra Bank

US FDA approval to Zydus Cadila - Angel Broking

HDFC Securities Institutional Research Desk: Cement Sector Thematic - Spotting the sweet spot

Bharat Forge - Expectation hurdle remains steep - ICICI Securities

Auto

Mutual Fund Review - September, 2020 - ICICI Securities

UTI AMC announces IPO date - Angel Broking

Asian Paints - Mr. Amarjeet Maurya - AVP - Mid Caps, Angel Broking Ltd

Britannia Industries - Mr. Amarjeet Maurya - AVP - Mid Caps, Angel Broking Ltd

Hexaware Technologies (Not Rated): Hexaware accepts 475/share as final delisting price - ICICI Securities

CAMS IPO - Day 2 Subscription - Angel Boking

Chemcon Speciality Chemicals - IPO subscribed 12.62 times on second day - Angel Broking

General insurance - Fire, health remain growth drivers, rising Covid claims a concern - ICICI Securities

Supreme Industries - Perfect recipe for rerating; upgrade to BUY - ICICI Securities

Titan Company - Best positioned to gain from faster-than-expected recovery. Upgrade to ADD - ICICI Securities

Sector Update - Telecom - Sep 23, 2020 - ICICI Securities

Allcargo Logistics - Highlights of Blackstone deal - ICICI Securities

I-direct Instinct - Gokaldas Exports

Economy: RBI's trilemma: allows for INR strength - Kotak

HCL Technologies - Company Update - ICICI Securities

Chemcon Speciality Chemicals - IPO Review - ICICI Securities

Angel Broking - IPO Note - YES Securities

TCS - Announcement of its blockhchain based solutions on Microsoft Azure - Angel Broking

Amber Enterpirses acquire Sidwal - Angel Broking

Dixon Technologies - Buy - YES Securities

HCL Technologies acquisition of DWS Limited - Angel Broking

Allcargo Logistics CFO Resignation - Angel Broking

Upgrade to BUY on Gateway Distriparks - Strengthening the balance sheet - HDFC Securities

BUY on ITD Cementation - Execution pickup awaited - HDFC Securities

Allcargo Logistics - Trying to stich through an integrated offering - ICICI Securities

Polymer price tracker - Other polymer (ex-PVC) prices too firm up - ICICI Securities

Angel Broking - IPO Review - ICICI Securities

IPO Review - Computer Age Management Services - ICICI Securities

Company Update - EIH Ltd - ICICI Securities

Gladiator Stocks - Godrej Properties - ICICI Securities

Company Update - Dr Reddy's Laboratories - ICICI Securities

Gladiator Stocks: Pharma Thematic - ICICI Securities

Company Update - Housing & Urban Development - ICICI Securities

Covid Recovery Pulse - E-Way bill generation shows recovery signs with auto volumes flat - ICICI Securities

Quant Pick - UltraTech Cement - ICICI Securities

Lupin & Cipla - Positive News - Angel Broking

Sterling and Wilson Solar Ltd - 106.71 MW order win - Angel Broking

Dr. Reddy's Laboratories - Settles Revlimid litigation in US - ICICI Securities

Natco Pharma - Natco to launch first generic Revlimid - ICICI Securities







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019